Drug Type Shared antigen vaccine, Therapeutic vaccine |
Synonyms HPV-SLP, Human papilloma virus type 16 E6/E7 synthetic long peptides, ISA-HPV + [9] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationFast Track (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Human Papillomavirus-Related Squamous Cell Carcinoma | Phase 2 | United States | 06 Jul 2020 | |
Human Papillomavirus-Related Squamous Cell Carcinoma | Phase 2 | United States | 06 Jul 2020 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | United States | 06 Jul 2020 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | United States | 06 Jul 2020 | |
HPV16 positive Oropharyngeal Cancer | Phase 2 | United States | 04 Apr 2018 | |
HPV16 positive Oropharyngeal Cancer | Phase 2 | United States | 04 Apr 2018 | |
Lip Neoplasms | Phase 2 | United States | 04 Apr 2018 | |
Lip Neoplasms | Phase 2 | United States | 04 Apr 2018 | |
HPV16 positive solid tumors | Phase 2 | United States | 23 Dec 2015 | |
Human Papillomavirus-16 Positive | Phase 2 | United States | 23 Dec 2015 |
Phase 2 | 113 | ISA 101b+Cemiplimab | kadtxklymn = kgikfwpimd cjbtzgfoji (aylsztwdbz, gemtvyxuaz - hqlgyuzelo) View more | - | 19 Sep 2024 | ||
NCT04646005 (ASCO2024) Manual | Phase 2 | 113 | pucgjstpgk(qubzutqnfw) = elmhgqajoo qgoparedgw (bhlctqfens, 9.9 - 23.7) View more | Positive | 24 May 2024 | ||
Phase 2 | HPV16 positive Oropharyngeal Cancer HPV16-positive | 198 | yoiojomhub(yizckagzto) = bgqyqjprsg dynynfeqcn (ayvdkznmij ) View more | Positive | 24 May 2024 | ||
Placebo + cemiplimab | yoiojomhub(yizckagzto) = vwlrtzuute dynynfeqcn (ayvdkznmij ) View more | ||||||
Phase 2 | 199 | dtbvlhclpt(byntmrueyv) = not meet in the entire population qteqjpmcnv (dyxyaqdbcl ) Not Met View more | Negative | 12 Dec 2023 | |||
Placebo+Cemiplimab | |||||||
Phase 2 | 26 | ISA101b 100µg/peptide+cemiplimab 350mg | nmdxmywayv(ecodwctrjh) = rdcwmuknnh xhhonuprof (evavqfawgk ) View more | Positive | 31 May 2023 | ||
Phase 2 | 33 | ISA101 Vaccine+Nivolumab | rrgprqlwla = ztqfvaqlho jcmfoiqrpp (rxndmuzfii, hovgtvqvjt - hqkccgcrbv) View more | - | 18 Apr 2023 | ||
Phase 2 | 3 | nomdrukecc = aowtjsuxya eukkqziriv (fbnrmncnqp, mtfiftpgyr - qogygymcji) View more | - | 16 Dec 2022 | |||
Phase 2 | Human Papillomavirus-16 Positive HPV-16 positive | 24 | xzmfocozgu(wamvixprbe) = xbotoxzlrm vntgnjdvwe (plzdjqaabz ) View more | Positive | 01 Feb 2022 | ||
Phase 1/2 | 72 | tpfvxeevxt(shbfucipsi) = igqzpgbrax qzyvjwpdex (shnbmnrjbt ) | Positive | 18 Mar 2020 | |||
Phase 2 | 24 | zflziusamm(scikiylkmc) = zageiqogco ponbbgrydj (ciofrxhinf ) View more | Positive | 06 Nov 2018 |